CEUTA HEALTHCARE LIMITED
Company Information
- Company Number
- 02974951
- Registered Address
- 3 Forbury Place, 23 Forbury Road, Reading, United Kingdom, RG1 3JH
- Status
- Active
- Employee Count
- 134
- Turnover
- £61,177,000
- EBITDA
- £4,460,000
Additional Details
- Company Type
- Private limited Company
- Incorporated On
- 6 October 1994
- Nature of Business
- 86900 - Other human health activities
- Industries
- Healthcare And Wellbeing
- Region
- South East
Time to Pay
Payment Timeline
Payment Features
Payment Score History
Company Review
Trend Analysis
The data reveals CEUTA HEALTHCARE LIMITED consistently pays beyond standard 30-day terms, with an average payment time of 38 days. Only 21% of payments are completed within 30 days, indicating a clear trend towards extended payment cycles. The predominant payment window is 31-60 days (55%), suggesting a generally predictable, albeit delayed, payment pattern.
Volatility Analysis
While 77% of payments are categorized as late, the significant concentration (55%) within the 31-60 day period provides some degree of predictability for suppliers regarding extended payment timelines. However, the 24% of payments exceeding 60 days introduces a notable risk of extended and less predictable delays. This long tail creates an element of uncertainty that could negatively impact a supplier's cash flow planning.
Summary Analysis
Suppliers should anticipate an average payment period of 38 days, with a high likelihood of payments extending beyond 30 days, before engaging with CEUTA HEALTHCARE LIMITED. Key decision factors include the supplier's ability to manage extended payment terms and potential cash flow strain from payments exceeding 60 days. It is recommended to implement risk mitigation strategies such as adjusting pricing, negotiating favorable upfront payment terms, or exploring invoice financing to manage the prevalent payment delays.
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Apr 2023 - 30 Apr 2023 | 20 Nov 2023 | 38 | 21% | 55% | 24% | 77% |
| 01 Oct 2022 - 31 Mar 2023 | 05 Jun 2023 | 39 | 52% | 38% | 10% | 61% |
| 01 Apr 2022 - 30 Sept 2022 | 01 Nov 2022 | 41 | 47% | 41% | 12% | 67% |
| 01 Oct 2021 - 31 Mar 2022 | 29 Apr 2022 | 39 | 49% | 40% | 11% | 55% |
| 01 Apr 2021 - 30 Sept 2021 | 29 Oct 2021 | 39 | 51% | 38% | 11% | 50% |
| 01 Oct 2020 - 31 Mar 2021 | 04 May 2021 | 53 | 52% | 35% | 13% | 63% |
| 01 Apr 2020 - 30 Sept 2020 | 03 Nov 2020 | 45 | 42% | 42% | 16% | 78% |
| 01 Oct 2019 - 31 Mar 2020 | 05 May 2020 | 46 | 57% | 31% | 12% | 76% |
| 01 Apr 2019 - 30 Sept 2019 | 31 Oct 2019 | 42 | 47% | 41% | 11% | 67% |
| 01 Oct 2018 - 30 Apr 2019 | 02 May 2019 | 46 | 54% | 31% | 15% | 75% |
| 01 Apr 2018 - 30 Sept 2018 | 29 Oct 2018 | 38 | 56% | 32% | 11% | 61% |
Payment Time Trends
Payment Distribution Trends
Invoice Payment Practices
This information is as reported by the business, and responses are in their own words.
Payment Terms
Standard payment terms
It is Company policy to agree appropriate terms of payment with each supplier, and to pay invoices in line with those terms subject to the timely submission of satisfactory invoices. The majority of our suppliers are on 30 day payment terms with the exception of import duty which is paid immediately.
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
75
Dispute Resolution Process
The Company is committed to dealing with its suppliers in a fair, honest and professional manner. We seek to resolve queries as quickly as possible to both parties satisfaction prior to payment being made. The invoice approver will reject an invoice they dispute and will advise the Purchase Ledger department why and the steps needed to resolve the issue. The approver will then contact their supplier to discuss the issue for resolution. Purchase Ledger will follow up outstanding queries each week and escalate to the approvers’ manager if a satisfactory resolution has not been found. When the invoice becomes aged this is escalated to the Finance Manager and then Finance Director for further action.
Other Payment Information
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Company Summary
CEUTA HEALTHCARE LIMITED operates as a private limited company within the healthcare sector. Its name clearly indicates its focus on healthcare-related activities and commercial operations.
This active private limited company was incorporated on 6 October 1994, identified by company number 02974951. Its registered office is located at 3 Forbury Place, 23 Forbury Road, Reading, United Kingdom, RG1 3JH, placing its primary operational base within the South East of England.
Companies operating within the UK healthcare sector typically provide a diverse range of services and products. These commonly include the provision of medical devices, pharmaceuticals, healthcare technology solutions, or direct healthcare services such as clinical support and consultancy.